Daniel T. Scavilla is CFO & VP at GLOBUS MEDICAL INC (GMED). They have made 3 open-market trades across 1 company since 2018, most recently 2026-05-22.
CIK 0001642439
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GMED | SELL · 10b5-1 | 2024-11-21 | 2024-11-25 | $85.00 | $11.1M | -1.9% | -0.6% | -5.8% |
| GMED | SELL · 10b5-1 | 2024-11-06 | 2024-11-08 | $80.02 | $4.8M | +1.7% | +0.9% | +7.0% |
| GMED | SELL | 2021-07-02 | 2021-07-07 | $78.41 | $7.8M | -2.5% | +0.4% | -2.3% |
| GMED | SELL | 2020-05-21 | 2020-05-26 | $55.09 | $5.5M | -1.1% | -20.0% | -2.8% |
| GMED | SELL | 2018-04-09 | 2018-04-11 | $50.00 | $5.0M | +3.2% | -3.1% | +1.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.